John Maraganore makes a bold promise ahead of #JPM21 — aiming to take Alnylam into the ranks of biotech's best

John Maraganore makes a bold promise ahead of #JPM21 — aiming to take Alnylam into the ranks of biotech's best

Source: 
Endpoints
snippet: 

Alnylam CEO John Maraganore is a big fan of five-year plans, and with JPM21 kicking off this week, he revealed his company’s newest ambitious goal — become a “top 5 biotech” by 2025.